Michael Motschmann

MIG Verwaltungs AG is a private equity investment firm headquartered in Munich, Germany. It was founded in 2004 by entrepreneurs and financial institutions, to follow up on the success of the venture capital investment vehicles Global Chance Fund and Global Asset Fund, with which MIG's management had been involved.

AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria.

HMW Emissionshaus AG is a German company that specializes in strategic asset building. The company is based in Pullach, Germany. The private company is the exclusive distributor of MIG funds and work with financial experts and investors to mobilize capital for sustainable investments and compelling return opportunities. The company's focus is on contributing to positive change.

HMW Innovations AG, founded in 2002, helps investors benefit from German successful company sales of the MIG funds. The company is based in Pullach, Germany and has subsidiaries in Germany. The private company's description highlights their focus on sustainable innovation and invites potential investors to learn more about their offerings. The text is originally in German but has been translated to English.

APK AG provides recovery services of raw materials such as fossil fuels like oil, coal, gas, and renewable resources like plants. It also provides grinding and screening processes for hard rocks. The company was founded by Wolfgang Lindner in 2008 and is headquartered in Merseburg, Germany.

cerbomed GmbH manufactures and supplies medical devices for treating epilepsy. It offers NEMOS, a transcutaneous vagus nerve stimulation unit that treats epilepsy patients. The company was founded by Stefan Dietrich and Timo Freitag in 2005 and is headquartered in Erlangen, Germany.

Protagen AG specializes in the development of novel diagnostic and companion diagnostic tests. Its products and services include GMP analyses, protein identification and analyses, proteome studies, UNIchip, clone and array, Bio-IT, Modiro as well as ProteinScape and Solver. The company was founded by Stefan Müllner, Helmut E. Meyer, Petra Weingarten and Martin Blüggel in 1997 and is headquartered in Dortmund, Germany.